Alberto Redaelli, PhD

This email address is being protected from spambots. You need JavaScript enabled to view it.

redaelliAlberto Redaelli is Full Professor in Bioengineering at Politecnico di Milano. He graduated in Mechanical Engineering in 1991 and he obtained the Ph.D. in Bioengineering in 1995 at Politecnico di Milano. In 2014, following postdoctoral and tenured professor positions, he was promoted to Professor in Biomechanics in the Department of Electronics, Information and Bioengineering. Currently, he serves as the Chair of the Bioengineering Division. He has founded and coordinates the Research Group on Biomechanics ( of the Department of Electronics, Information and Bioengineering.

Over his academic life, he has mainly focused on the development of new enabling tools, with the aim of finding new solutions to biological and clinical problems. His research is mainly in the field of cardiovascular biomechanics and computational fluid dynamics, both experimental and computational, and embraces pioneering studies on fluid structure interaction approaches, design of innovative cardiovascular devices and prostheses, and valve mechanics studies with emphasis on patient specific modeling from imaging data. In recent years, his research interests have been extended to smaller scales to include molecular modeling of molecular motors and collagen, and microfluidics for the study of blood damage mechanics and myocardial tissue physiopathology. Alberto Redaelli has published 240+ ISI peer reviewed journal papers (Scopus H-index 46, 7500+ citations); he has been local coordinator of 1 Marie Curie project and two STREP project in FP6, and 1 ICT-VPH project and one IRSES Marie Curie in FP7. Currently, he is the coordinator of 1 Marie Curie ITN project and local coordinator of one RISE project in H2020.

Finally, he is the inventor of 18 patents (starting from 2001), 9 of which have been transferred to companies. He is co-founder of two Politecnico spin-off company, BiomimX (2017) and Artiness (2018). BiomimX ( develops clinically relevant in vitro models of human organs and pathologies for testing drug and medical devices. BiomimX has won the first prize at the Switch-to-Product competition 2018, the EIT Headstart 2018 award and the Termis Business Plan Competition 2018. Artiness ( develops holographic applications for healthcare. Artiness has won the Lumbardy CNA contest 2019, the Vodafone Action for 5G 2019 award the 11th European Open Innovation Contest di NTTData and participates to the start-up accelerator programs Elevator by Endeavor, B-Heroes and Microsoft for Startups .

Download files (temporary links):

2) Mobilità all'estero - Istruzioni

3) Mobilità all'estero - Piano delle corrispondenze